Evidence map›Paper›PMID 25932201›Full record

ArticleInternational journal of clinical and experimental medicine2015

High tenascin-C levels cause inadequate myocardial blush grade in patients with acute myocardial infarction.

Ozlem Arican Ozluk, Dursun Topal, Erhan Tenekecioglu, Tezcan Peker, Mustafa Yilmaz, Kemal Karaagac, Fahriye Vatansever, Bedrettin Boyraz, Omur Aydın

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 5 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Ozlem Arican OzlukDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Dursun TopalDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Erhan TenekeciogluDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Tezcan PekerDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Mustafa YilmazDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Kemal KaraagacDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Fahriye VatanseverDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Bedrettin BoyrazDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Omur AydınDepartment of Cardiology, Bursa Ihtisas Training And Research Hospital Bursa, Turkey.
Bursa Yuksek Ihtisas Egitim Ve Arastirma Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimCoronary artery disease (CAD) and its serious clinical form, ST segment elevated myocardial infarction (STEMI) has been the leader within the death causes around the world and in our country. In STEMI, the main objective is providing the myocardial reperfusion. In our study, it was aimed to investigate the predictive value of tenascin-C level for the degree of myocardial reperfusion in patients with STEMI.

methodsIn our study, 58 patients admitted to our hospital with acute anterior STEMI were included. All the patients had underwent primary percutaneous intervention for the single-vessel disease at left anterior descending coronary artery. After admission to coronary care unit tenascin-C levels were measured. Subjects were classified according to their myocardial blush grades (MBG); MBG 0, MBG 1 and MBG 2 were groupped as Group I, MBG 3 was groupped as Group II. The groups were compared according to their tenascin-C levels and other parameters.

resultsBetween group I (n = 31, mean age 55 ± 12.5) and group II (n = 27, mean ages 49.3 ± 11.1); tenascin-C, troponin I and CK-MB levels were significantly higher in group I compared to the group-II (P < 0.001; P < 0.001 and P < 0.05; respectively). In group I, left ventricular ejection fraction (LVEF) was significantly lower (P < 0.001), left ventricular end-diastolic volume and left ventricular end-systolic volume were significantly higher (P = 0.03) as compared to group II. In group I, ST-segment resolution at ECG was worse (P = 0.003). In correlation analyzes, tenascin-C was significantly positively correlated with troponin-I (r = 0.596; P < 0.001) and CRP (r = 0.615, P < 0.001). Tenascin-C was significantly negatively correlated with MBG, LVEF and ST-segment resolution (r = -0.626, P < 0.001, r = -0.411, P = 0.002 and r = -0.631; P < 0.001, respectively).

conclusionBased on our study, it can be estimated that in patients with high tenascin-C levels myocardial reperfusion was inadequate, even underwent successfull PCI. In this context, increased tenascin-C may help predict not only left ventricular remodelling and prognosis but also the effectiveness of primary PCI.

Indexed as

myocardial blush gradeMyocardial infarctiontenascin-C

Identifiers

PMID25932201
PMCPMC4402848
OpenAlexW2419429771

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.